Cargando…
Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging
PURPOSE: Human epidermal growth factor receptor-2 (HER2) overexpression is a predictor of response to anti-HER2 therapy in breast and gastric cancer. Currently, HER2 status is assessed by tumour biopsy, but this may not be representative of the larger tumour mass or other metastatic sites, risking m...
Autores principales: | Goldstein, Robert, Sosabowski, Jane, Livanos, Maria, Leyton, Julius, Vigor, Kim, Bhavsar, Gaurav, Nagy-Davidescu, Gabriela, Rashid, Mohammed, Miranda, Enrique, Yeung, Jenny, Tolner, Berend, Plückthun, Andreas, Mather, Stephen, Meyer, Tim, Chester, Kerry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315530/ https://www.ncbi.nlm.nih.gov/pubmed/25391547 http://dx.doi.org/10.1007/s00259-014-2940-2 |
Ejemplares similares
-
Anti-HER2 imaging agents for breast cancer imaging
por: Tolner, B, et al.
Publicado: (2010) -
Thermostable designed ankyrin repeat proteins (DARPins) as building blocks for innovative drugs
por: Schilling, Johannes, et al.
Publicado: (2021) -
Designed Ankyrin Repeat Protein (DARPin) Neutralizers of TcdB from Clostridium difficile Ribotype 027
por: Peng, Zeyu, et al.
Publicado: (2019) -
Comparison of tumor-targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2
por: Vorobyeva, Anzhelika, et al.
Publicado: (2019) -
Crystal structures of HER3 extracellular domain 4 in complex with the designed ankyrin-repeat protein D5
por: Radom, Filip, et al.
Publicado: (2021)